CELH
Celsius Holdings, Inc.
CELH has the edge over KHC overall, supported by stronger valuation and stronger modeled upside.
KHC
The Kraft Heinz Company
KHC has lower modeled downside risk, despite its lower overall score.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
KHC Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Healthy | |
| Weak |
KHC's cash flow is currently healthy, and its revenue is stable, but its profitability and balance sheet are under pressure.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
KHC PE Valuation
KHC has no meaningful PE right now: it lost money over the past year.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
CELH has the edge over KHC on the outlook, with more favorable earnings and revenue expectations.
KHC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Decline | |
| Stable | |
| Weakening | |
| Limited | |
| Moderate |
Analysts expect KHC's earnings and profitability to decline, with its revenue holding steady.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH has the edge over KHC on earnings quality, reporting a profit while its opponent remains loss making.
KHC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.97 | — |
| Q3 2026 | -$2.91 | +$0.82 |
| Q2 2026 | -$2.85 | +$1.64 |
| Q1 2026 | -$4.85 | -321% |
| Q4 2025 | -$4.93 | -318% |
| Q3 2025 | -$3.73 | -436% |
| Q2 2025 | -$4.49 | -388% |
| Q1 2025 | $2.19 | -4.4% |
| Q4 2024 | $2.26 | -2.2% |
KHC lost $2.91 per share over the past year, a smaller loss than the year before.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over KHC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over KHC on profitability, with a higher operating margin.
KHC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $6.1B | -2% |
| Q2 2026 | $6.3B | -1.4% |
| Q1 2026 | $6B | +0.8% |
| Q4 2025 | $6.4B | -3.4% |
| Q3 2025 | $6.2B | -2.3% |
| Q2 2025 | $6.4B | -1.9% |
| Q1 2025 | $6B | -6.4% |
| Q4 2024 | $6.6B | -4.1% |
KHC's revenue fell from its 2022 peak and has held roughly level since: $6.1B last quarter, down 2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | -2.1 points |
| Q2 2026 | -103% | +23 points |
| Q1 2026 | 19% | -1 points |
| Q4 2025 | 17% | +18 points |
| Q3 2025 | 16% | +18 points |
| Q2 2025 | -126% | -134 points |
| Q1 2025 | 20% | -0.4 points |
| Q4 2024 | -0.6% | -20 points |
KHC's operating margin was 14% last quarter, down 2.1 points from the same quarter a year ago.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.
KHC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $702M | -29% |
| Q2 2026 | $893M | -13% |
| Q1 2026 | $766M | +59% |
| Q4 2025 | $1.2B | +2.6% |
| Q3 2025 | $986M | +16% |
| Q2 2025 | $1B | +47% |
| Q1 2025 | $482M | +1% |
| Q4 2024 | $1.1B | +1.7% |
KHC has the edge over CELH on cash flow, with more consistent year-over-year improvement.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has the edge over KHC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
KHC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +6M shares |
| 1 year | +0.5% | +6M shares |
| 3 years | -3.5% | -43M shares |
| 5 years | -3.6% | -44M shares |
| Available history | -2.6% | -32M shares |
KHC has 1.2B diluted shares, up 0.5% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $52M |
| Q2 2026 | $4M |
| Q1 2026 | $23M |
| Q4 2025 | $1M |
| Q3 2025 | — |
| Q2 2025 | $210M |
| Q1 2025 | $225M |
| Q4 2024 | $450M |
KHC spent $80M buying back its own shares over the past year, down 91% from the year before.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has more cash than debt.
KHC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2025 | 7.7x | High |
| Q4 2024 | 7.0x | High |
| Q3 2024 | 4.7x | High |
| Q2 2024 | 4.0x | Elevated |
| Q1 2024 | 3.4x | Elevated |
| Q4 2023 | 3.4x | Elevated |
| Q3 2023 | 3.5x | Elevated |
| Q2 2023 | 3.5x | Elevated |
KHC's net debt is about 7.7 years of its operating earnings (EBITDA), up from 3.4 years a year ago.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
KHC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 50.9 | Neutral |
KHC's weekly RSI is 51 (neutral) and its Stochastic is 51 (neutral).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
KHC PE vs Consumer Defensive Sector
| Metric | KHC | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 19x | — |
KHC has no meaningful PE right now: it lost money over the past year.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 29% below its 200-week average.
KHC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $23.8 | 3.1% above |
| 20 week MA | $24.7 | 0.8% below |
| 50 week MA | $24.0 | 2% above |
| 100 week MA | $25.9 | 5.6% below |
| 200 week MA | $30.8 | 20% below |
KHC's trend is mixed: it's above two of its five weekly moving averages, and 20% below its 200-week average.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.
KHC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $31.6 | $35.0 | +11% |
| 2021 | $35.0 | $35.3 | +0.8% |
| 2022 | $35.3 | $40.5 | +15% |
| 2023 | $40.5 | $37.0 | -8.7% |
| 2024 | $37.0 | $30.7 | -17% |
| 2025 | $30.7 | $24.1 | -21% |
| 2026 YTD | $24.1 | $24.5 | +1.5% |
KHC has the edge over CELH on returns for 2026, with the stronger performance.